Susan Desmond-Hellmann
speaker
362 appearances
1 recordings
1 series
first heard Apr 2025
last heard Apr 2025
Susan Desmond-Hellmann’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
And look, there may be human conditions for which ivermectin helps.
Beyond what we know. And I think that's an opportunity for somebody to study it. Good for them.
Well, I think it's a drug that's an anti-smarty pants drug.
That's what it is.
Nothing wrong with that. We've done that for other things.
One of the things that I've did over the last four years is participate in the President's Council of Advisors on Science and Technology and co-chaired a report on the future of public health. And we ended up thinking that we're focusing on the workforce. One of the remedies for the issue you and I just talked about is having a broader set of people who we think of as the public health workforce.
And I think people who are interested in ivermectin, farmers, people who are up close and personal to some of the things with this bird flu. There are a number of different folks who would be really interesting to involve in public health efforts, and we typically don't.
And so I think that's one of the ways that we can go forward in public health is to think about how do we define public health and what does it look like?
On the surface, it's such a great thing. I think that's why Make America Healthy Again resonates for people. People universally want to be healthy. They want their families to be healthy. This is a universal thing. And how to capture that and make that real, not ivory tower, but real for people who just want their families to have a chance of being healthy. I think that's a real positive.
So I joined the OpenAI board almost a year ago now, when they had had in November of 2023, what they call the blip, which is CEO fired, board changed over. And I have been so impressed by the intellect, the commitment, the sense of responsibility of folks at OpenAI. I hope this is maybe a little crazy, but here's what I hope. If I had a top two things for AI,
One is in some of the things we've been talking about in product development. I mean, I love product development. I think it is the best job on earth. You get to make new medicines for people who are sick. You go home and tell your mom and dad that they're happy. So what if we could take the tool of AI and make easy the things we can make easy? So you don't use AI to change a clinical trial.
I still want to know, does your tumor shrink? Do you feel better? Do you have side effects? But there's a lot of study reports. There's toxicology reports. There are a lot of things that are labor and paperwork that are actually very important to establishing the safety, especially, but also the efficacy of a drug.
I think using AI more and more on pieces of the clinical trials process so that if something takes time, it's because it's benefiting a human, not because we just couldn't do it fast enough. So the clinical trials, I think, still has some opportunities for that.
If you said the entire clinical trials program for a drug is six years, let's just make that up.
IND to approval. I would want to cut it down by two years.
I think we could be on a path to that. Now, the challenge of it is going to be if you say this example I like to give because it makes sense for people. If I'm changing five-year survival, if this is sort of a mature, established thing, I got to wait five years. I can estimate things and I can work with FDA to make sure if people can benefit.
You can always do that.
I think that the other thing is you and I both know if you have 500 patients in a trial and you look at safety, that's so limited. If you have a much more AI driven, why don't we follow safety in every patient?
Ongoing. So I think the opportunities in clinical trials are massive. The other thing I would love to see is a change in the things that cause burnout of nurses and physicians and others in the hospital.
Not in clinical trials. This is healthcare. Healthcare should have tools where it's easier to decrease the load, the burden on both caregivers and families. I think that should be doable. It's not that hard.
Showing 321–340 of 362 · page 17 of 19
← Previous
Next →